Fibrocell
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Fibrocell and buy or sell other stocks, ETFs, and their options commission-free!About FCSC
Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on September 28, 1992 and is headquartered in Exton, PA.
CEOJohn M. Maslowski
CEOJohn M. Maslowski
Employees—
Employees—
HeadquartersExton, Pennsylvania
HeadquartersExton, Pennsylvania
Founded1995
Founded1995
Employees—
Employees—
FCSC Key Statistics
Market cap29.27M
Market cap29.27M
Price-Earnings ratio-12.91
Price-Earnings ratio-12.91
Dividend yield—
Dividend yield—
Average volume66.51K
Average volume66.51K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.28
52 Week high$3.28
52 Week low$1.45
52 Week low$1.45
Stock Snapshot
As of today, Fibrocell(FCSC) shares are valued at $3.00. The company's market cap stands at 29.27M, with a P/E ratio of -12.91.
On 2025-11-06, Fibrocell(FCSC) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 66.51K.
Over the past 52 weeks, Fibrocell(FCSC) stock has traded between a high of $3.28 and a low of $1.45.
Over the past 52 weeks, Fibrocell(FCSC) stock has traded between a high of $3.28 and a low of $1.45.